Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
nabilone (cesamet) (1 trial)
Muscle Spasticity (Phase 2)
Neuralgia (Phase 2)
Spinal Cord Injuries (Phase 2)
Trials (1 total)
Trial APIs (1 total)